Literature DB >> 12657855

Deactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock.

Ko Takakura1, Wen Xiaohong, Kenji Takeuchi, Yoshikazu Yasuda, Satoru Fukuda.   

Abstract

BACKGROUND: Vascular hyporeactivity to catecholamines limits successful treatment of hypotension in septic shock. Large amounts of nitric oxide (NO) and superoxide anion (O(2)(-1).) are produced in response to bacterial endotoxins and/or inflammatory cytokines. NO reacts with O(2)(-1). to form the potentially toxic NO metabolite, peroxynitrite (ONOO(-1)). The purpose of this study was to investigate whether ONOO(-1) decreases the vasocontractile activity of norepinephrine.
METHODS: Norepinephrine was treated with ONOO(-1) or 3-morpholinosydonimine-N-ethyl-carbamine (SIN-1; an ONOO(-1) producer) in a 5 x 10(-2) m sodium phosphate buffer solution at pH 7.4, and absorbance of the product was measured spectrophotometrically at 295 and 370 nm. Norepinephrine pretreated with ONOO(-1) was administered to isolated rat thoracic aortas to observe contractions in functional experiments. The rate constant between norepinephrine and ONOO(-1) was determined via a competition assay with cysteine in functional experiments. Norepinephrine pretreated with ONOO(-1) was injected intravenously into anesthetized rats to measure blood pressure.
RESULTS: Norepinephrine pretreated with ONOO(-1) was confirmed spectrally as oxidized norepinephrine. Norepinephrine pretreated with ONOO(-1) decreased its vasocontractile force in an ONOO(-1) (10(-6), up to 3 x 10(-4) m) concentration-dependent manner (EC(50) = 5.1 x 10(-5) m). The decrease in its force was lower at pretreatment with ONOO(-1) in a lower pH buffer. A rate constant for the ONOO(-1)-norepinephrine reaction was 6 x 10(2) m/s. Norepinephrine (10(-7) m) incubated with SIN-1 (10(-3) m) decreased its vasocontractile force in an incubation time-dependent manner. Administration of norepinephrine pretreated with ONOO(-1) to anesthetized rats caused no significant change in arterial blood pressure.
CONCLUSIONS: These results indicate that norepinephrine was oxidized and deactivated by ONOO(-1). This deactivation may, at least in part, account for the hyporeactivities of vasocontraction to norepinephrine in septic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657855     DOI: 10.1097/00000542-200304000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  17 in total

1.  Antioxidant therapy in sepsis.

Authors:  Gerd Albuszies; Uwe Bernd Brückner
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

2.  Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock.

Authors:  Roberto Alberto De Blasi; Stefano Palmisani; Daniela Alampi; Marco Mercieri; Rocco Romano; Saul Collini; Giovanni Pinto
Journal:  Intensive Care Med       Date:  2005-10-05       Impact factor: 17.440

Review 3.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite.

Authors:  Bahar Tunctan; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; C Kemal Buharalioglu; Seyhan Sahan-Firat; Belma Korkmaz; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-09-05       Impact factor: 3.072

Review 5.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

6.  The peroxynitrite catalyst WW-85 improves microcirculation in ovine smoke inhalation injury and septic shock.

Authors:  Dirk M Maybauer; Marc O Maybauer; Csaba Szabó; Martin Westphal; Lillian D Traber; Andrew L Salzman; David N Herndon; Daniel L Traber
Journal:  Burns       Date:  2011-02-22       Impact factor: 2.744

7.  The peroxynitrite catalyst WW-85 improves pulmonary function in ovine septic shock.

Authors:  Dirk M Maybauer; Marc O Maybauer; Csaba Szabó; Robert A Cox; Martin Westphal; Levente Kiss; Eszter M Horvath; Lillian D Traber; Hal K Hawkins; Andrew L Salzman; Garry J Southan; David N Herndon; Daniel L Traber
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

8.  High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics?

Authors:  Roman Sykora; Jiri Chvojka; Ales Krouzecky; Jaroslav Radej; Thomas Karvunidis; Veronika Varnerova; Ivan Novak; Martin Matejovic
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

9.  Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.

Authors:  Seyhan Sahan-Firat; Meryem Temiz-Resitoglu; Demet Sinem Guden; Sefika Pinar Kucukkavruk; Bahar Tunctan; Ayse Nihal Sari; Zumrut Kocak; Kafait U Malik
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

10.  Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.